BAX Stock Analysis: Buy, Sell, or Hold?
BAX - Baxter International Inc.
$17.78
0.47 (2.72%)
▲
5d:
+1.66%
30d:
+1.02%
90d:
-4.97%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Apr 30, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 7.9/10
Get Alerted When BAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BAX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: BAX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$22.00
Based on 4.5% avg growth
INTRINSIC VALUE TODAY
$13.66
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BAX is currently trading at $17.78, which is considered fair relative to its 30-day fair value range of $17.00 to $18.26. The stock's valuation (Forward PE: 8.8) is in line with its historical norms (8.8). At these levels, the market is pricing in 0.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, BAX is in a strong downtrend. The price is approaching resistance at $18.09. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BAX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.12 (+24.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BAX is in a strong downtrend. The price is approaching resistance at $18.09. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BAX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.12 (+24.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$17.00 -
$18.26
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.4% below Wall St target ($22.12)
- NEUTRAL: Market pricing in 0.3% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$17.00 -
$18.26
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$16.48
Resistance Level
$18.09
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.84
Wall Street Target
$22.12
(+24.4%)
Revenue Growth (YoY)
2.9%
Earnings Growth (YoY)
237.9%
Profit Margin
-9.7%
Valuation Premium vs History
+0.3% premium
PE vs Historical
8.8 vs 8.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.3%
(market-implied from PE analysis)
1-Year Target
$17.83
(+0%)
2-Year Target
$17.89
(+1%)
3-Year Target
$17.94
(+1%)
3-Yr Target (if PE normalizes)
(PE: 9→9)
PE COMPRESSION
$17.86
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 4.9%)
$51.21
(+188%)
Base:
(SPY PE: 8.8, Growth: 4.9%)
$20.54
(+16%)
Bear:
(PE: 7.5, Growth: 4.9%)
$17.46
(-2%)
Share & Embed Analysis
Last updated: May 14, 2026 9:09 PM ET
Data refreshes hourly during market hours. Next update: 10:09 PM
Data refreshes hourly during market hours. Next update: 10:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BAX showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Michael T. McCaul
BUY
2026-02-17
Ro Khanna
BUY
2026-02-17
Ro Khanna
BUY
2026-01-29
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$577 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 53 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$180 | 52 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$271 | 59 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 64 BUY |
Advanced BAX Option Strategies
Professional options setups generated by AI based on today's BAX price and gamma walls.
